Report Overview:
The Blood Micro-sampling Medical Devices market encompasses a range of medical tools used to collect small quantities of blood for diagnostic purposes. Lancets, a key component of this market, are small pricking needles used to obtain drops of blood for testing, primarily for patients managing cardiovascular and endocrine disorders. Designed for single use, lancets ensure patient safety and reduce the risk of contamination by being disposed of immediately after use. The rising prevalence of chronic diseases has driven the demand for these devices in home settings, hospitals, and clinics.
Market Value:
The global Blood Micro-sampling Medical Devices market was valued at approximately USD 1,857 million in 2024. Projections indicate significant growth, with the market expected to reach USD 2,905.60 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.10%.
By Types:
• Safety Lancets
• Ordinary Lancets
By Applications:
Hospitals & Clinics
Home Use
Key players include:
• Cardinal Health
• ARKRAY
• ICU Medical
• Owen Mumford
• HemoCue
• Greiner Bio One
• Including or Excluding key companies relevant to your analysis.
